comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 13:59:00 - browse：638

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Disclosing genetic information: not as worrisome as once feared

Wikipedia

WSS

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

An outdated Medicare rule harms dementia patients with anxiety

An outdated Medicare rule harms dementia patients with anxiety

BD to buy Edwards patient monitoring unit for $4.2 billion

FDA approves Moderna’s RSV vaccine, its second licensed product

Data don't support strong claims for Covid

explore

comprehensive

focus

As demand for Covid shots wanes, Moderna seeks its next success

FTC loses bid to block Novant's North Carolina hospital merger

Psychedelics group wrestles with new pharma identity

With FDA staff opposed to Sarepta therapy, top official intervened

State Dept. review finds Biden bears some blame for Afghanistan failures

Weight bias in eating disorder treatment complicated by new weight loss drugs

Tori Bowie and the unacceptable rates of Black maternal death

Donald Trump's relentless attacks on special counsel Jack Smith

The cancer drug shortage isn’t new — and neither are the solutions

STAT wants to know your pick for a great summer read or listen

explore

CMS got Medicare Advantage quality rating wrong, judge rules

The battle over the Brookhaven Landfill on Long Island

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Eli Lilly’s Zepbound improved liver scarring in mid

CMS got Medicare Advantage quality rating wrong, judge rules

Illumina board agrees to spin off Grail, as divestment plans proceed

explore

knowledge

Wikipedia

focus